PG vs CL Stock Comparison: AI Score, Valuation, Performance and Upside
Procter & Gamble and Colgate-Palmolive are two of the most iconic consumer staples companies, both known for dominant global brands, consistent dividend growth, and pricing power. P&G is the larger, more diversified portfolio company; Colgate is more concentrated in oral care and pet nutrition with a heavier developing market exposure. Both are high-quality dividend compounders, but P&G's scale and portfolio breadth give it slightly more defensive characteristics.
P&G is the larger, more defensive consumer staples compounder with unmatched pricing power across a diversified category portfolio; Colgate offers higher developing market growth exposure and Hill's pet nutrition as an additional compounding engine.
PG holds the edge across 3 of 5 key metrics in this comparison. CL has delivered stronger 1-year price return (+7.76% vs -6.18%), though PG has the better forward P/E setup (19.78x vs 22.09x for CL). On fundamentals, CL is growing revenue faster (4.90%), while PG maintains the higher operating margin (22.08%) — a classic growth-versus-profitability split. Analyst consensus implies similar upside for both: +9.71% for PG and +9.04% for CL.
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- want the broadest consumer staples portfolio with pricing power across 65 global brand categories
- prioritize dividend Dividend King status with 67+ consecutive annual increases
- prefer more US revenue exposure versus Colgate's higher emerging market concentration
- value the sheer scale advantage enabling R&D and marketing investment that smaller peers cannot match
- want concentrated exposure to global oral care — a category with secular demand from hygiene awareness
- value Hill's pet nutrition as an accelerating high-margin growth engine within the portfolio
- believe emerging market consumer spending will drive above-market organic revenue growth long-term
- are comfortable with higher FX exposure in exchange for developing world growth leverage
| Metric | PG | CL |
|---|---|---|
| AI scorei | 41.2 | 41.5 |
| AI ranki | #1077 | #1038 |
| Latest closei | $146.39 | $87.47 |
| 1M returni | +1.18% | -3.96% |
| 6M returni | +1.46% | +2.76% |
| 1Y returni | -6.18% | +7.76% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | PG | CL |
|---|---|---|
| 1Y ago | $9.56K (-4.4%) started 2025-09-22 | $11.02K (+10.2%) started 2025-09-22 |
| 5Y ago | $12.32K (+23.2%) started 2021-09-22 | $13.7K (+37.0%) started 2021-09-22 |
| 10Y ago | $27.22K (+172.2%) started 2016-09-22 | $18.33K (+83.3%) started 2016-09-22 |
Hypothetical — past performance does not guarantee future results.
| Metric | PG | CL |
|---|---|---|
| Market capi | $340.02B | $72.34B |
| Trailing P/Ei | 22.11 | 35.73 |
| Forward P/Ei | 19.78 | 22.09 |
| Price/Salesi | 4.58 | N/A |
| EV/Revenuei | 4.21 | 3.76 |
| Analyst targeti | $160.61 | $98.95 |
| Target upsidei | +9.71% | +9.04% |
| Metric | PG | CL |
|---|---|---|
| Revenue growthi | 1.50% | 4.90% |
| Earnings growthi | -15.50% | -5.50% |
| EPS growthi | -15.50% | -5.50% |
| FCF margini | +15.26% | +16.43% |
| Operating margini | 22.08% | 20.97% |
| Profit margini | 18.44% | 9.68% |
| ROIC proxyi | 30.29% | 267.37% |
| Return on equityi | 30.29% | 267.37% |
| Dividend yieldi | 2.97% | 2.34% |
| Payout ratioi | 64.33% | 82.28% |
| Dividend growth streaki | No increase yet | No increase yet |
| Betai | 0.38 | 0.33 |
| Debt/equityi | 64.49 | 1388.16 |
| Current ratioi | 0.68 | 1.03 |
| Quick ratioi | 0.41 | 0.56 |
Over the past year, PG and CL have moved strongly in the same direction (correlation of 0.73), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | PG | CL |
|---|---|---|---|
| 1Y | Growthi | -4.36% | +10.22% |
| CAGRi | -4.39% | +10.27% | |
| Volatilityi | 19.41% | 22.48% | |
| Sharpe ratioi | -0.37 | 0.35 | |
| Sortino ratioi | -0.52 | 0.52 | |
| Max drawdowni | 16.15% | 17.48% | |
| Current drawdowni | 12.45% | 11.77% | |
| Avg drawdowni | 8.42% | 6.67% | |
| Ulcer Indexi | 9.82% | 8.16% | |
| Max daily dropi | 3.56% | 3.85% | |
| Max wkly dropi | 8.12% | 7.16% | |
| 5Y | Growthi | +11.84% | +25.04% |
| CAGRi | +2.26% | +4.57% | |
| Volatilityi | 18.13% | 19.10% | |
| Sharpe ratioi | -0.03 | 0.10 | |
| Sortino ratioi | -0.05 | 0.13 | |
| Max drawdowni | 23.77% | 29.94% | |
| Current drawdowni | 17.53% | 18.27% | |
| Avg drawdowni | 8.29% | 10.38% | |
| Ulcer Indexi | 10.38% | 12.80% | |
| Max daily dropi | 6.23% | 5.22% | |
| Max wkly dropi | 8.92% | 8.10% | |
| 10Y | Growthi | +108.41% | +46.08% |
| CAGRi | +7.62% | +3.86% | |
| Volatilityi | 19.18% | 19.91% | |
| Sharpe ratioi | 0.25 | 0.06 | |
| Sortino ratioi | 0.35 | 0.09 | |
| Max drawdowni | 23.77% | 29.94% | |
| Current drawdowni | 17.53% | 18.27% | |
| Avg drawdowni | 6.59% | 9.06% | |
| Ulcer Indexi | 8.87% | 11.19% | |
| Max daily dropi | 8.74% | 9.78% | |
| Max wkly dropi | 16.27% | 12.85% |
| Category | PG | CL |
|---|---|---|
| Company | The Procter & Gamble Company | Colgate-Palmolive Company |
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Household & Personal Products | Household & Personal Products |
| Core business | Procter & Gamble is the world's largest consumer products company, with a portfolio of 65 brands spanning baby care, fabric care, feminine care, home care, hair care, personal care, and grooming. Its brand portfolio includes Tide, Pampers, Gillette, Always, and Head & Shoulders — each #1 or #2 in their respective global categories. P&G's strategy centers on premium-tier innovation within each category and consistent price increases ahead of commodity cost inflation. | Colgate-Palmolive is a global consumer products company best known for its Colgate oral care brand — the world's leading toothpaste — plus Hill's pet nutrition, household products (Palmolive), and personal care. Oral care accounts for approximately 40% of revenue, and Colgate has commanding 40%+ global market share in toothpaste in many regions. Hill's pet nutrition is its highest-growth segment, benefiting from the premiumization of pet care globally. |
| Investor focus | Investors track organic revenue growth (volume plus pricing), gross margin recovery after years of commodity headwinds, emerging market penetration especially in Asia and Africa, and dividend growth — P&G has increased its dividend for 67+ consecutive years (Dividend King). | Investors track Colgate's oral care market share globally (key brand health indicator), Hill's pet nutrition growth rates, gross margin recovery, and organic revenue growth versus pricing/volume split. Colgate's emerging market revenue concentration (50%+ of sales) is both a growth driver and FX risk. |
- Portfolio of dominant global brands with #1 or #2 share in most categories
- Proven ability to take consistent price increases while maintaining market share — a true pricing power signal
- 67+ consecutive years of dividend increases — one of the longest streaks of any S&P 500 company
- World's leading toothpaste brand with commanding market share in developing markets
- Hill's pet nutrition is a high-growth, premium category with durable consumer trends
- Extensive emerging market distribution infrastructure provides revenue in high-growth geographies
- Volume elasticity — prolonged price increases eventually slow unit volume as consumers trade down
- Private label competition intensifying, particularly in fabric care and paper products
- Emerging market exposure creates FX headwinds as local currencies weaken versus the dollar
- 50%+ revenue from emerging markets creates significant FX translation headwinds
- Oral care category can face private label competition in value-sensitive markets
- Hill's voluntary recalls (2019-2020) created reputation risk in the high-margin pet segment
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.